Results 211 to 220 of about 9,264,457 (358)
On the specific attitude of I131 uptake of thyroid in the thyroid functiontests of Graves' disease
Tomio TOMONAGA
openalex +2 more sources
The innovation of this work lies in the use of supramolecular interfacial effect of pillararene (CP5) to regulate the performance of CeOx by promoting the charge separation and transportation, which can enhance the SDT efficacy by large ROS generation and TME regulation.
Congcong Wang+6 more
wiley +1 more source
Treatment of Graves' Disease: Faster Remission or Longer but Safe, That Is the Question. [PDF]
Jung CH.
europepmc +1 more source
Graves' disease: immunological and immunogenetic indicators of relapse [PDF]
Tjerk W.A. de Bruin+6 more
openalex +1 more source
Diabetic wound healing is blocked by persistent inflammation and oxidative stress. Bioactive substances like growth factors and Hsts promote repair but lack long‐term stability. Herein, a platelet membrane‐coated nanoparticle system (PNP) is proposed to achieve enhanced retention of aggregation‐induced emissive (AIE) molecular‐modified Hst1 (Hst1‐AIE ...
Xiaoxuan Lei+9 more
wiley +1 more source
Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves' disease: literature review. [PDF]
Sinha A+4 more
europepmc +1 more source
Dexamethasone Suppression Tests in Graves' Disease [Abridged]
I. C. Gilliland, Manjushree Ghose
openalex +1 more source
Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease. [PDF]
C. A. Hardisty, Donald Munro
openalex +1 more source
Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
This review addresses the gap between strong evidence for the involvement of amyloid fibrils in neurodegeneration and the failure of anti‐amyloid therapies, a phenomenon herein termed the “amyloid paradox.” To address this paradox, we provide a comprehensive summary of the current understanding of fibrils' pathogenic properties and mechanisms ...
Maksim I. Sulatsky+3 more
wiley +1 more source